Truist Financial Corp Penumbra Inc Transaction History

Truist Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$175.6 - $291.43 $386,495 - $641,437	-2,201 Closed	0 $0
Q4 2020 Nov 19, 2021	SELL	$174.98 - $272.83 $208,401 - $324,940	-1,191 Reduced 35.11%	2,201 $386,000
Q4 2020 Feb 18, 2021	BUY	$174.98 - $272.83 $155,907 - $243,091	891 Added 35.63%	3,392 $594,000
Q3 2020 Nov 13, 2020	SELL	$185.27 - $238.73 $8,522 - $10,981	-46 Reduced 1.81%	2,501 $486,000
Q2 2020 Aug 14, 2020	BUY	$153.32 - $191.72 $145,040 - $181,367	946 Added 59.09%	2,547 $456,000
Q1 2020 May 15, 2020	BUY	$124.34 - $193.76 $199,068 - $310,209	1,601 New	1,601 $258,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.